Investment Analysts’ New Coverage for February 3rd (AKTS, ARE, BDX, CCRN, DIS, EVO, HBAN, LMB, MDT, MPT)

Investment Analysts’ new coverage for Tuesday, February 3rd:

TD Cowen initiated coverage on shares of Aktis Oncology (NASDAQ:AKTS). They issued a buy rating on the stock.

Leerink Partners assumed coverage on shares of Aktis Oncology (NASDAQ:AKTS). They issued an outperform rating and a $31.00 target price on the stock.

Bank of America Corporation assumed coverage on shares of Aktis Oncology (NASDAQ:AKTS). They issued a buy rating and a $34.00 price target on the stock.

JPMorgan Chase & Co. initiated coverage on shares of Aktis Oncology (NASDAQ:AKTS). The firm issued an overweight rating and a $30.00 target price on the stock.

The Goldman Sachs Group, Inc. started coverage on shares of Alexandria Real Estate Equities (NYSE:ARE). The firm issued a neutral rating and a $60.00 target price on the stock.

Citigroup Inc. assumed coverage on shares of Becton, Dickinson and Company (NYSE:BDX). Citigroup Inc. issued a buy rating and a $233.00 target price on the stock.

Wedbush started coverage on shares of Cross Country Healthcare (NASDAQ:CCRN). They issued a neutral rating and a $11.00 price target on the stock.

Morgan Stanley initiated coverage on shares of Walt Disney (NYSE:DIS). Morgan Stanley issued an overweight rating and a $135.00 price target on the stock.

Berenberg Bank started coverage on shares of Evotec (NASDAQ:EVO). Berenberg Bank issued a buy rating on the stock.

Evercore ISI began coverage on shares of Huntington Bancshares (NASDAQ:HBAN). Evercore ISI issued an outperform rating and a $21.00 price target on the stock.

JPMorgan Chase & Co. began coverage on shares of Limbach (NASDAQ:LMB). They issued a neutral rating and a $100.00 target price on the stock.

Citigroup Inc. started coverage on shares of Medtronic (NYSE:MDT). Citigroup Inc. issued a buy rating and a $117.00 price target on the stock.

Maxim Group started coverage on shares of Medical Properties Trust (NYSE:MPT). Maxim Group issued a buy rating and a $8.00 price target on the stock.

JPMorgan Chase & Co. began coverage on shares of MSA Safety Incorporporated (NYSE:MSA). JPMorgan Chase & Co. issued a neutral rating and a $200.00 price target on the stock.

Lake Street Capital began coverage on shares of Plus Therapeutics (NASDAQ:PSTV). Lake Street Capital issued a buy rating and a $2.00 price target on the stock.

Piper Sandler started coverage on shares of SAP (NYSE:SAP). The firm issued an overweight rating on the stock.

Guggenheim began coverage on shares of Sagimet Biosciences (NASDAQ:SGMT). The firm issued a buy rating and a $27.00 price target on the stock.

Wedbush began coverage on shares of STAAR Surgical (NASDAQ:STAA). The firm issued a neutral rating and a $26.00 price target on the stock.

Wedbush began coverage on shares of TaskUs (NASDAQ:TASK). The firm issued an outperform rating and a $15.00 target price on the stock.